Efficacy Study of CPC634 (CriPec ® Docetaxel) in Platinum Resistant Ovarian Cancer

Conditions:   Cancer;   Ovarian Cancer Intervention:   Drug: CPC634 (CriPec® docetaxel) Sponsor:   Cristal Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials